Orchard Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Blue Owl Capital Holdings LP(0%)
Orchard Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Deep Track Capital, LP(0%),Deep Track Biotechnology Master Fund, Ltd.(0%)等
Orchard Therapeutics | SC 13G:超过5%持股股东披露文件-Blue Owl Capital Holdings LP(6.85%)
Orchard Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(0.0%),Peter Kolchinsky(0.0%)等
Orchard Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(0.000%),Abigail P. Johnson(0.000%)
Orchard Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(6.961%),Abigail P. Johnson(6.961%)
Orchard Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Beryl Capital Management LLC(6.9%),Beryl Capital Management LP(6.9%)等
Orchard Therapeutics | 15-12G:终止注册
Orchard Therapeutics | EFFECT:其他
Orchard Therapeutics | EFFECT:其他
Orchard Therapeutics | 4:持股变动声明-董事 Secor Alicia
Orchard Therapeutics | 4:持股变动声明-董事 Rowland Charles A Jr
Orchard Therapeutics | 4:持股变动声明-高管 THOMAS FRANK E
Orchard Therapeutics | 4:持股变动声明-董事 GERAGHTY JAMES A
Orchard Therapeutics | 4:持股变动声明-董事 Beck Joanne T.
Orchard Therapeutics | 4:持股变动声明-高管 Gaspar Bobby
Orchard Therapeutics | 4:持股变动声明-董事 Curnutte John T
Orchard Therapeutics | 4:持股变动声明-董事 Altschuler Steven
Orchard Therapeutics | 4:持股变动声明-董事 Dunoyer Marc
Orchard Therapeutics | S-8 POS:员工福利计划证券登记(修正)